26/08/2025
iLoF selected by Johnson & Johnson Innovation, advancing its precision medicine platform, Optomics® in Japan 🚀🗾
We are honored to share that iLoF has been recognized as an awardee of the Johnson & Johnson Innovation LLC Japan Smart Healthy Aging QuickFire Challenge, advancing further pilots of our platform in Japan.
Being selected from a global pool of leading companies and innovators, this recognition from Johnson & Johnson Innovation LLC is a tremendous encouragement for our team and mission, reinforcing the potential of our platform to help advance how aging-related conditions are diagnosed and treated.
By piloting our flagship Optomics® platform in Japan, we are aiming to enable advanced patient identification and enhance clinical development pathways across the Asia-Pacific region.
We’re truly grateful for this recognition from Johnson & Johnson Innovation LLC, whose 135+ year legacy in global health continues to inspire innovation and progress in medicine worldwide.
🔬 Optomics®, powered by AI and photonics, is uniquely positioned to accelerate precision medicine - perfectly aligned with Johnson & Johnson Innovation’s use of AI/ML for improving patient stratification and trial design. We’re especially proud to bring this work to Japan, a country leading global innovation in healthy aging, and join a thriving ecosystem that will amplify our mission across the region.
A heartfelt thank you to Johnson & Johnson Innovation LLC for this opportunity and for believing in our vision. We remain committed to shaping the future of medtech and healthy aging.
More info:
https://jnjinnovation.com/innovation-challenges/Japan-Smart-Healthy-Aging-QuickFire-Challenge-2024